Jorge A. Arbelbide

Buenos Aires, C, Argentina

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 33 publications

Are HLA-Haploidentical Relatives a Donor Choice for Patients With Severe Aplastic Anemia? A GATMO-TC Experience.

Are HLA-Haploidentical Relatives a Donor Choice for Patients With Severe Aplastic Anemia? A GATMO-TC Experience.

Journal: Transplantation and cellular therapy

Published: March 09, 2026

Letermovir prophylaxis for cytomegalovirus infection in hematopoietic transplantation with post-transplant cyclophosphamide.

Letermovir prophylaxis for cytomegalovirus infection in hematopoietic transplantation with post-transplant cyclophosphamide.

Journal: Medicina

Published: June 27, 2025

Assessing the Relevance of Non-molecular Prognostic Systems for Myelodysplastic Syndrome in the Era of Next-Generation Sequencing.

Assessing the Relevance of Non-molecular Prognostic Systems for Myelodysplastic Syndrome in the Era of Next-Generation Sequencing.

Journal: Annals of laboratory medicine

Published: February 16, 2024

Alternative Dosing Schedules of Azacitidine: A Real-World Study Across South American Centers.

Alternative Dosing Schedules of Azacitidine: A Real-World Study Across South American Centers.

Journal: Clinical lymphoma, myeloma & leukemia

Published: December 30, 2023

Cardiac and autologous stem cell transplantation hematopoietic in patients with AL amyloidosis.

Cardiac and autologous stem cell transplantation hematopoietic in patients with AL amyloidosis.

Journal: Archivos de cardiologia de Mexico

Published: November 16, 2023

Results with allo-SCT in patients with relapsed/refractory HL treated with anti-PD-1, a multicenter retrospective cohort study: subcommittee of transplantation and cellular therapy (GATMO-TC) of the Argentinian Hematology Society (SAH).

Results with allo-SCT in patients with relapsed/refractory HL treated with anti-PD-1, a multicenter retrospective cohort study: subcommittee of transplantation and cellular therapy (GATMO-TC) of the Argentinian Hematology Society (SAH).

Journal: Leukemia & lymphoma

Published: September 16, 2022

Acquired FXI deficiency in a systemic lupus erythematosus patient: Evolution and coagulation phenotypic changed to lupus anticoagulant during immunosuppressive therapy.

Acquired FXI deficiency in a systemic lupus erythematosus patient: Evolution and coagulation phenotypic changed to lupus anticoagulant during immunosuppressive therapy.

Journal: International journal of laboratory hematology

Published: March 24, 2022

Autologous stem cell transplantation in patients older than 65 years with multiple myeloma: a real-world study.

Autologous stem cell transplantation in patients older than 65 years with multiple myeloma: a real-world study.

Journal: Hematology, transfusion and cell therapy

Published: March 20, 2022

Donor Age Influences Graft-Versus-Host Disease Relapse-Free Survival after Allogeneic Stem Cell Transplant in Elderly Patients in Two Countries from Latin America.

Donor Age Influences Graft-Versus-Host Disease Relapse-Free Survival after Allogeneic Stem Cell Transplant in Elderly Patients in Two Countries from Latin America.

Journal: Hematology/oncology and stem cell therapy

Published: September 08, 2021

Decrease in Mortality from Sepsis: Impact of the Multidisciplinary Program for the Hematologic Patient at Very High Risk.

Decrease in Mortality from Sepsis: Impact of the Multidisciplinary Program for the Hematologic Patient at Very High Risk.

Journal: Indian journal of hematology & blood transfusion : an official journal of Indian Society of Hematology and Blood Transfusion

Published: June 05, 2021

Temporal trends in hematopoietic stem cell transplantation in Argentina between 2009 and 2018: A collaborative study by GATMO-TC and INCUCAI.

Temporal trends in hematopoietic stem cell transplantation in Argentina between 2009 and 2018: A collaborative study by GATMO-TC and INCUCAI.

Journal: Hematology, transfusion and cell therapy

Published: March 28, 2021

Prognostic assessment for chronic myelomonocytic leukemia in the context of the World Health Organization 2016 proposal: a multicenter study of 280 patients.

Prognostic assessment for chronic myelomonocytic leukemia in the context of the World Health Organization 2016 proposal: a multicenter study of 280 patients.

Journal: Annals of hematology

Published: December 29, 2020

Showing 1-12 of 33

Last Updated: 09/26/2026